Search results for "From Annals of Internal Medicine"


 
Results 11 - 20 of about 62 for "From Annals of Internal Medicine".
Sort by: Relevance | Newest | Oldest

Infliximab biosimilar safe, effective for Crohn's disease

CT-P13 and infliximab were compared in infliximab-naive patients who had recently started treatment with either drug.
https://gastroenterology.acponline.org/archives/2018/12/28/6.htm
28 Dec 2018

Going ‘Beyond the Guidelines' to treat gallstone pancreatitis

Physicians from Beth Israel Deaconess Medical Center in Boston discuss the care of a patient with recurrent acute pancreatitis who decides to delay cholecystectomy until after hospital discharge.
https://gastroenterology.acponline.org/archives/2019/02/22/7.htm
22 Feb 2019

Patients had high adherence to HCV treatment delivered in opioid agonist therapy programs

The hepatitis C virus (HCV) treatment completion rate was 97% among all participants, including those actively using drugs.
https://gastroenterology.acponline.org/archives/2019/04/26/6.htm
26 Apr 2019

Experts go ‘Beyond the Guidelines' to debate screening, management of NAFLD

Hepatologists from Beth Israel Deaconess Medical Center and University of Michigan Medical Center offered differing opinions on screening and management for nonalcoholic fatty liver disease (NAFLD).
https://gastroenterology.acponline.org/archives/2019/08/23/8.htm
23 Aug 2019

Case of ‘autobrewery syndrome’ effectively treated with fecal transplant

The 47-year-old man in Belgium had been experiencing intermittent episodes when he felt drunk despite not consuming any alcohol.
https://gastroenterology.acponline.org/archives/2020/08/28/6.htm
28 Aug 2020

COVID-19 outbreak linked to fecal aerosol transmission in one study

Nine COVID-19-positive patients from three families in China lived in vertically aligned apartments in the same building connected by drainage pipes in the master bathrooms.
https://gastroenterology.acponline.org/archives/2020/09/25/8.htm
25 Sep 2020

About 1 in 8 commercially insured patients received potential surprise bill for colonoscopy

Of more than 1 million elective colonoscopies in commercially insured U.S. patients, about 12% involved out-of-network claims at a median cost of $418 per potential surprise bill, a study found.
https://gastroenterology.acponline.org/archives/2020/10/23/9.htm
23 Oct 2020

Linked color imaging endoscopy improved detection of upper GI cancers

An industry-funded trial in Japan found that in high-risk adults, linked color imaging endoscopy improved detection of upper GI neoplasms compared with conventional white light imaging.
https://gastroenterology.acponline.org/archives/2020/10/23/8.htm
23 Oct 2020

Long-term survival did not differ with laparoscopic vs. open liver surgery in metastatic colon cancer

In a single-center randomized trial in Norway, five-year rates of overall and recurrence-free survival were 54% versus 55% and 30% versus 36%, respectively, in patients who received laparoscopic versus open surgery.
https://gastroenterology.acponline.org/archives/2020/11/20/7.htm
20 Nov 2020

Antibiotic may prevent hepatic encephalopathy after TIPS in patients with cirrhosis

A French trial found that 34% of patients who received rifaximin before and after placement of a transjugular intrahepatic portosystemic shunt (TIPS) had hepatic encephalopathy versus 53% of those who received placebo, with no differences in adverse events or transplant-free survival.
https://gastroenterology.acponline.org/archives/2021/02/26/7.htm
26 Feb 2021

Result Page: Prev   1   2   3   4   5   6   7   Next